A study to compare whether there is a difference in the improvement of swallowing function between two types of anti-gastric ulcer drugs for elderly people with a history of gastric ulcer and dysphagia.

Not Applicable

• Conditions: Swallowing dysfunctionGastric ulcer; Swallowing dysfunction, Elderly People; D003680

• Registration Number: JPRN-jRCT1021230018
• Lead Sponsor: Seki Yumika

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-07-29
• Last Update Posted: 1 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

Elderly people aged 65 years or older with a history of gastric ulcer who have subjective symptoms of swallowing dysfunction or who have been diagnosed with swallowing dysfunction, and who are taking antacids.

Exclusion Criteria

1.Difficult to take gastric ulcer drugs due to severe dementia or deterioration of consciousness.
2.Patients with a history of limb amputation near the wrist or ankle.
3.Continuously taking test drugs (polaprezinc, rebamipide) for more than 1 week within 2 weeks before informed consent.
4.Have been hospitalized for more than 1 week within 2 weeks before informed consent.
5.Patients who are judged to be unsuitable to participate in this study by the principal investigator or co-investigator.
6.Patients who are allergic to test drugs (polaprezinc, rebamipide) .
7.Patients who are judged to be difficult to participate in the study due to complication of psychosis or psychiatric symptoms.
8.Patients who are judged to be unable to perform the test due to severe dementia, etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified